Skip to main content

Advertisement

SpringerLink
Log in

Clinicopathological Characteristics of 20 Cases of Hepatocellular Carcinoma with Bile Duct Tumor Thrombi

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Hepatocellular carcinoma (HCC) with bile duct tumor thrombi (BDTT) is a rare type of primary liver cancer, and its clinical and pathological characteristics remain to be defined.

Aims

To investigate the clinical and pathological characteristics of HCC with BDTT.

Methods

Among 676 HCC patients who underwent surgical treatment from Dec. 2002 to Dec. 2008 at the author’s hospital, HCC with BDTT was identified in 20 patients. The clinical and pathological characteristics of the 20 patients were measured or analyzed retrospectively. The integrity of the involved bile duct was examined macroscopically and microscopically, the expression of liver stem cell markers was investigated by immunohistochemistry, and the Kaplan–Meier method was adopted for evaluating survival.

Results

Among the 20 patients, the diameter of the primary tumor was less than 5 cm in 13 patients (range: 0.5–10 cm, mean 4.47 ± 0.68 cm). Most of the primary tumors lacked an intact tumor capsule (15/20, 75%), had simultaneous blood vessel invasion (12/20, 60%), and were poorly differentiated (13/20, 65%). There was no evidence of bile duct wall infiltration by the tumor cells macroscopically or microscopically. The positive rate of the liver stem cell markers c-kit, CD90, CD133, and EpCAM was 90, 90, 85 and 85%, respectively. Postoperative overall survival rates at 1, 2, and 3 years were 73.1, 41.1, and 20.6%, respectively. The log-rank test showed that the overall survival rates were significantly worse for HCC patients with BDTT than for HCC patients without BDTT (P = 0.016).

Conclusions

HCC with BDTT has aggressive characteristics and the long-term prognosis is extremely dismal.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. El-Serag HB, Rudolph L. Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–2576.

    Article  CAS  PubMed  Google Scholar 

  2. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–1917.

    Article  PubMed  Google Scholar 

  3. Kojiro M, Kawabata K, Kawano Y, et al. Hepatocellular-carcinoma presenting as intra-bile duct tumor-growth—a clinicopathologic study of 24 cases. Cancer. 1982;49:2144–2147.

    Article  CAS  PubMed  Google Scholar 

  4. Qin LX, Tang ZY. Hepatocellular carcinoma with obstructive jaundice: diagnosis, treatment and prognosis. World J Gastroenterol. 2003;9:385–391.

    PubMed  Google Scholar 

  5. Liu Q, Chen J, Li H, et al. Hepatocellular carcinoma with bile duct tumor thrombi: Correlation of magnetic resonance imaging features to histopathologic manifestations. Eur J Radiol. 2009.

  6. Shiomi M, Kamiya J, Nagino M, et al. Hepatocellular carcinoma with biliary tumor thrombi: Aggressive operative approach after appropriate preoperative management. Surgery. 2001;129:692–698.

    Article  CAS  PubMed  Google Scholar 

  7. Peng SY, Wang JW, Liu YB, et al. Surgical intervention for obstructive jaundice due to biliary tumor thrombus in hepatocellular carcinoma. World J Surg. 2004;28:43–46.

    Article  PubMed  Google Scholar 

  8. Peng B-G, Liang L-J, Li S-Q, et al. Surgical treatment of hepatocellular carcinoma with bile duct tumor thrombi. World J Gastroenterol. 2005;11:3966–3969.

    PubMed  Google Scholar 

  9. Qin L-X, Ma Z-C, Wu Z-Q, et al. Diagnosis and surgical treatments of hepatocellular carcinoma with tumor thrombosis in bile duct: Experience of 34 patients. World J Gastroenterol. 2004;10:1397–1401.

    PubMed  Google Scholar 

  10. American Joint Committee on Cancer. AJCC cancer staging manual. 6th ed. New York: Springer; 2002:145–149.

    Google Scholar 

  11. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. Ca-a Cancer J Clin. 2005;55:74–108.

    Article  Google Scholar 

  12. Shirabe K, Kajiyama K, Harimoto N. Prognosis of hepatocellular carcinoma accompanied by microscopic portal vein invasion. World J Gastroenterol. 2009;15:2632–2637.

    Article  PubMed  Google Scholar 

  13. Mallory TB, Castleman B, Parris EE. Case records of the Massachusetts General Hospital. N Eng J Med. 1947;237:673–676.

    Article  Google Scholar 

  14. Lin TY, Chen KM, Chen YR. Icteric type hepatoma. Med Chir Dig. 1975;4:267–270.

    CAS  PubMed  Google Scholar 

  15. Tseng JH, Hung CF, Ng KK. Icteric-type hepatoma: Magnetic resonance imaging and magnetic resonance cholangiographic features. Abdom Imaging. 2001;26:171–177.

    Article  CAS  PubMed  Google Scholar 

  16. Buckmaster MJ, Schwartz RW, Carnahan GE, Strodel WE. Hepatocellular-carcinoma embolus to the common hepatic duct with no detectable primary hepatic tumor. Am Surg. 1994;60:699–702.

    CAS  PubMed  Google Scholar 

  17. Yeh CN, Jan YY, Lee WC, Chen MF. Hepatic resection for hepatocellular carcinoma with obstructive jaundice due to biliary tumor thrombi. World J Surg. 2004;28:471–474.

    Article  PubMed  Google Scholar 

  18. Huang GT, Sheu JC, Lee HS, et al. Icteric type hepatocellular carcinoma: Revisited 20 years later. J Gastroenterol. 1998;33:53–56.

    Article  CAS  PubMed  Google Scholar 

  19. Satoh S, Ikai I, Honda G, et al. Clinicopathologic evaluation of hepatocellular carcinoma with bile duct thrombi. Surgery. 2000;128:779–783.

    Article  CAS  PubMed  Google Scholar 

  20. Huang JF, Wang LY, Lin ZY, et al. Incidence and clinical outcome of icteric type hepatocellular carcinoma. J Gastroenterol Hepatol. 2002;17:190–195.

    Article  PubMed  Google Scholar 

  21. Edmondson HA, Steiner PE. Primary carcinoma of the liver—a study of 100 cases among 48, 900 necropsies. Cancer. 1954;7:462–503.

    Article  CAS  PubMed  Google Scholar 

  22. Narita R, Oto T, Mimura Y, et al. Biliary obstruction caused by intrabiliary transplantation from hepatocellular carcinoma. J Gastroenterol. 2002;37:55–58.

    Article  PubMed  Google Scholar 

  23. Ikenaga N, Chijiiwa K, Otani K, et al. Clinicopathologic characteristics of hepatocellular carcinoma with bile duct invasion. J Gastrointest Surg. 2009;13:492–497.

    Article  PubMed  Google Scholar 

  24. Sell S. Heterogeneity and plasticity of hepatocyte lineage cells. Hepatology. 2001;33:738–750.

    Article  CAS  PubMed  Google Scholar 

  25. Yamashita T, Forgues M, Wang W, et al. EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma. Cancer Res. 2008;68:1451–1461.

    Article  CAS  PubMed  Google Scholar 

  26. Papoulas M, Theocharis S. Primary liver tumors: Origin and target therapy. Expert Opin Ther Targets. 2009;13:957–965.

    Article  CAS  PubMed  Google Scholar 

  27. Liu C, Schreiter T, Dirsch O, et al. Presence of markers for liver progenitor cells in human-derived intrahepatic biliary epithelial cells. Liver Int. 2004;24:669–678.

    Article  CAS  PubMed  Google Scholar 

  28. Mishra L, Banker T, Banker T, et al. Liver stem cells and hepatocellular carcinoma. Hepatology. 2009;49:318–329.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by The Special Research Foundation of the National Nature Science Foundation of China (30872487)

Financial disclosure and commercial sponsorship

Each author certifies that he had no financial or commercial sponsorship to disclose.

Author information

Authors and Affiliations

  1. Department of General Surgery, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, 510120, Guangzhou, Guangdong Province, China

    Xian-huan Yu, Lei-bo Xu, Chao Liu, Rui Zhang & Jie Wang

Authors
  1. Xian-huan Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lei-bo Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chao Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rui Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jie Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chao Liu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yu, Xh., Xu, Lb., Liu, C. et al. Clinicopathological Characteristics of 20 Cases of Hepatocellular Carcinoma with Bile Duct Tumor Thrombi. Dig Dis Sci 56, 252–259 (2011). https://doi.org/10.1007/s10620-010-1256-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-010-1256-8

Keywords

Search

Navigation